Trump, Industry Disagree Over Buy-American Order’s Impact On Prices

The buy-American executive order that the president will sign Thursday (Aug. 6) aims to avoid raising drug prices by making it easier to build advanced U.S. manufacturing facilities that make drugs from start to finish, White House trade advisor Peter Navarro said Thursday morning. But drug industry lobbyists said merely speeding government approvals of domestic manufacturing facilities will not offset the increase in manufacturing costs from requiring domestic production. President Donald Trump will announce the executive order at an event...